RxDoctor Payments Data

Alex Olivera

Podiatrist · Toms River, NJNPI 1801250675

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (52.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 45.7% of the total. Reporting peaked in 2021 at $2,316 and has fallen 66.1% since, to $785 in 2025. Among podiatrist clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,762in general payments, 2019–2025

Across 98 payments — averaging $79.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$4K
  • Arthrex$1K
  • Smith+Nephew$954
  • Stryker$495
  • Organogenesis Inc.$444
  • Integra Lifesciences Corporation$162
  • plus $778 from 13 others

What the payments were for

  • Travel & lodging$6969%
  • Food & beverage$2,96238%
  • Education$4,10453%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,762 in reported general payments places this provider in the 90th percentile of 382 podiatrist providers in New Jersey.

See all podiatrist providers in New Jersey

Medicare billing

Part B allowed, 2024
$121,133
Medicare patients
463
Services billed
2,078

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$153
Methylprednisolone14$112
Ketoconazole11$105
Silver Sulfadiazine18$78

Paid to pharmacies, not to this prescriber.

Other podiatrist in Toms River

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →